Aurobindo Pharma (AUROPHARMA) — Corporate Action

📢 Key Event
A1 Biochem USA Inc acquisition completed via USD 1 million cash subscription

🔄 What Changed
100% subsidiary ownership established; USD 1 million cash outflow; new US CRO subsidiary created

🔮 What's Next
Not applicable

💡 Investor Takeaway
This creates a US-based contract research platform to expand R&D capabilities beyond India.

Aurobindo Pharma announced its step-down subsidiary A1 Biochem Labs (India) acquired 100% of newly incorporated A1 Biochem USA Inc by subscribing to 10,000 USD 100 shares for USD 1 million cash on September 11, 2026, establishing a US presence for contract research and development services.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AUROPHARMA ✨ Ask AI About This

About Aurobindo Pharma Ltd (AUROPHARMA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹94,419.51 Cr P/E: 25.6 ROE: 9.8% ROCE: 12.8% Div Yield: 0.24%

View full AUROPHARMA stock details →

📡 Get AI alerts when AUROPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AUROPHARMA — Free

💡 Ask AI about this filing

"How does this USD 1 million investment impact Aurobindo's overall R&D budget?" "What specific CRO contracts are planned with US pharmaceutical clients?" "How will this subsidiary affect Aurobindo's consolidated financial statements?"

Ask AI Free →

📊 More AUROPHARMA filings

See all AUROPHARMA filings →

🔥 Also filed on 12 September 2026

539200 Noble Polymers Ltd Corporate Action NOVARTIND Novartis India Ltd Announcement KOTYARK Kotyark Industries Ltd Announcement 531083 Nihar Info Global Ltd Financial Results 526570 Midwest Energy Ltd Corporate Action KRYSTAL Krystal Integrated Services Ltd Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AUROPHARMA files new disclosures

Track AUROPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AUROPHARMA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd